Johnson & Johnson, U.S. agree on drug discounts, new plants
Key Terms
tariffs
regulatory
Tariffs are taxes imposed by a government on goods…
J&J strikes deal with U.S. government to cut drug prices, gain tariff exemptions
Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
Johnson & Johnson MedTech submits Ottava surgical robot to FDA
Johnson & Johnson MedTech (NYSE: JNJ) + announced today that it submitted its Ottava surgical robotic system to…
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Chicago, IL – January 6, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…
Johnson & Johnson halts mid-stage trial of experimental eczema drug
Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now
24/7 Wall St Verizon offers the highest yield at 6.59% with a 0.32 beta and 19 consecutive years…
Google’s Gemini puts OpenAI on shakier ground, with big market implications
Almost every night, for almost a decade, I got a phone call between 7:00 and 7:01 p.m. ET.…
Trump, RFK Jr. and Texas lawsuits slam Kenvue
Kenvue, the company that makes Tylenol, is fighting on both the political and scientific fronts. The latest blow…
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a…
Texas sues Tylenol makers over RFK Jr autism claims saying they failed to state ‘risk of taking drug while pregnant’
Texas has launched a lawsuit against manufacturers of Tylenol, claiming they deceived customers by failing to mention unproven…
Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug’s autism risks
(Reuters) -The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney General…
J&J in talks to acquire Protagonist Therapeutics
Johnson & Johnson (J&J) is in discussions to purchase Protagonist Therapeutics, a move that would enhance their current…